Key stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about Merck
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Merck will hold its first-quarter 2025 sales and earnings conference call on April 24, where executives will provide an overview of the company's performance for the quarter. The call will be accessible via a live audio webcast, with a replay and financial disclosures available on Merck's website[2].
Merck faces a class action lawsuit alleging the company made false and/or misleading statements about its Gardasil revenue outlook and growth, particularly in China. On February 4, 2025, Merck disclosed a significant decline in Gardasil sales and inventory issues, leading to a nearly 10% drop in stock price[2][4].
Merck announced positive results from the Phase III ZENITH clinical trial of Winrevair (sotatercept-csrk) for pulmonary arterial hypertension, showing a 76% reduction in the risk of all-cause death, lung transplantation, and hospitalization compared to placebo. The trial was stopped early due to overwhelming efficacy[5].
Open job positions at Merck
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

